Mercedes Benz Group's Daimler South East Asia has produced its Ocean Protocol pilot-based Acentrik blockchain platform.
A non-fungible token (NFT) represents each Acentrik dataset and a metadata hash is stored in it.
Acentrik is squarely targeted at enterprise users, including Know Your Business and extensive access controls.
Since Acentrik is not domain specific, the platform could be used for insurance information, clinical trials data, or anything else.
Although consumers can use a stablecoin rather than a cryptocurrency to pay for data, public blockchains like Polygon or the Ethereum Rinkeby test network carry out the transactions.
However, Polygon gas fees must be paid with the MATIC cryptocurrency. The underlying data can be stored on IPFS or AWS S3.


Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Thailand Inflation Remains Negative for 10th Straight Month in January
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



